Recursion Pharmaceuticals, Inc.

NASDAQ:RXRX

6.64 (USD) • At close November 4, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

20232022202120202019
Operating Activities:
Net Income -328.066-239.476-186.479-87.006-61.879
Depreciation & Amortization 32.46511.7568.4054.4422.489
Deferred Income Tax -364.69800.8271.7571.054
Stock Based Compensation 53.50327.90914.8424.2921.385
Change In Working Capital -50.257104.921-0.30630.8340.408
Accounts Receivables -7.756-0.0020.114-0.005-0.027
Inventory 00.0027.8354.3570
Accounts Payables -0.9871.7671.745-0.185-0.34
Other Working Capital -41.514103.154-1026.6670.775
Other Non Cash Items 369.27311.3664.0970.282-0.499
Operating Cash Flow -287.78-83.524-158.614-45.399-57.042
Investing Activities:
Investments In Property Plant And Equipment -12.552-37.359-39.798-6.735-3.91
Acquisitions Net 1.8440231.946-2.60
Purchases Of Investments 0.5970-301.13700
Sales Maturities Of Investments 0.48230.60869.19100
Other Investing Activites -0.597230.308-231.9460.5950
Investing Cash Flow -10.228193.249-271.744-8.74-3.91
Financing Activities:
Debt Repayment -0.766-0.09-12.798-0.077-11.183
Common Stock Issued 140.899143.711462.901239.812119.705
Common Stock Repurchased 00000
Dividends Paid 00000
Other Financing Activities 140.13310.7248.4376.411.888
Financing Cash Flow 140.133154.345458.54246.135120.41
Other Information:
Effect Of Forex Changes On Cash 0.188-0.307000
Net Change In Cash -156.396263.76328.182191.99659.458
Cash At End Of Period 394.796559.112295.349267.16775.171